Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.40
0.121.39%
Last update: Oct 15, 11:01 AM
ProMIS Neurosciences Inc (PMN) Stock Price, Quote, News & History
PMNNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ProMIS Neurosciences (NASDAQ:PMN) through any online brokerage.
Other companies in ProMIS Neurosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
ProMIS Neurosciences has a consensus price target of $52.33.
The stock price for ProMIS Neurosciences (NASDAQ: PMN) is $8.4 last updated October 15, 2026 at 11:01 AM EDT.
There are no upcoming dividends for ProMIS Neurosciences.
ProMIS Neurosciences does not have any upcoming earnings scheduled.
There is no upcoming split for ProMIS Neurosciences.
ProMIS Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
